2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Hydrophthalmos: new trials by email Literature Review of Hydrophthalmos trials Research Report on Hydrophthalmos
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Determine the Safety and Tolerability of 2 Concentrations of QLS-101 QLS-101ophthalmic solution 1%, QLS-101ophthalmic solution 2% - Sturge-Weber Syndrome (SWS), Glaucoma | Phase 2 | Completed | Qlaris Bio, Inc. | 3 | 2021-10-19 | 2025-01-20 |
| Efficacy and Safety of Topically Applied Medical Therapy for the Treatment of Pediatric Glaucoma Latanoprost, Dorzolamide - Childhood Glaucoma | Phase 2 | Completed | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 37 | 2009-07-01 | 2019-09-27 |
Glaucoma (1) · Ocular Hypertension (1) · Sturge-Weber Syndrome (1)
Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Eye Abnormalities (2) · Eye Diseases (2) · Glaucoma, Open-Angle (2) · Infant, Newborn, Diseases (2) · Angiomatosis (1) · Cardiovascular Diseases (1) · Glaucoma (1) · Hemangioma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Vascular Tissue (1) · Nervous System Diseases (1) · Neurocutaneous Syndromes (1)
Latanoprost (1) · dorzolamide (1)
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (1) · Qlaris Bio, Inc. (1)
Italy (1) · United States (1)
B. Wirostko, M.D. (1) · Luciano Quaranta, MD (1)
2008 (1)